ArticlePharmacoEconomics2026
Cure Models: What is Meant by a Survival 'Plateau', and Do Experts Agree on What Constitutes One?
Article in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCure models are becoming more popular for modelling survival data where long-term survival, or 'cure', is considered plausible. One criterion for considering fitting cure models is evidence for a plateau in the Kaplan-Meier survival curve. However, what constitutes a mathematical definition of a plateau in survival probability is unclear, and visual inspections of survival curves are subjective.
objectiveWe investigate these issues and clarify what is meant by a plateau in this context.
methodsWe begin by describing an activity where five experts were presented with 10 survival curves from oncology trials. They were asked to rank these curves in order of their potential suitability for mixture cure modelling. We explore mathematically what features of data are required to produce a positive estimated cure fraction under an exponential mixture cure model. We show how these results can be generalised to a Weibull mixture cure model. A case study was performed using one of the survival curves.
resultsWe found weak correlations between the experts' rankings. Mathematical investigations revealed the features of data required for mixture cure models to be potentially useful, such as a decreasing event rate, but this is highly model dependent. The case study illustrated similar statistical issues.
conclusionsWe conclude that a precise definition of the extent to which a Kaplan-Meier survival curve demonstrates a plateau is likely to prove elusive. External evidence or subject matter expert knowledge about the plausibility of cure must therefore play a key role.
Indexed as
Identifiers
41085859What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.